Search

everythinglearnresearchcommunity

for

Search:↓

Menopause affects hair and skin; more research needed for treatment.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Finasteride helps hair growth by decreasing cell death in hair follicles.

Finasteride affects hair growth by changing caspase and XIAP levels, potentially treating hair diseases.

Erythropoietin helps hair grow and could be a potential treatment for hair loss.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

Ovulation disorders are a major cause of infertility and menstrual problems in women.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

A thorough history and examination are crucial for diagnosing skin diseases, which affect up to a third of people. This includes details about skin lesions, medication, general health, lifestyle, family, and contacts, as well as examining the rash, hair, nails, and mucous membranes. Changes in hair and nails can also indicate other medical and skin disorders.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

New methods to test hair growth treatments have been developed.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

Micrografting is the most effective surgical method for permanent hair restoration.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Hair transplantation and micrografting, used for baldness, involve moving hair follicles from hair-rich to bald areas, requiring careful procedure and post-care for success.

Hair transplantation is highly effective with careful technique and attention to patient needs.

Baldness might be caused by scalp weight pressing on hair follicles.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.